ARCHIVES

In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist

This article is from The Cancer Letter archive.

Vol. 07 No. 45 | November 6, 1981

Download PDF Visit The Full Archive

Related Articles

HRT Doesn’t Raise Cancer Risk Following Oophorectomy

October 28, 2005

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

Smoking Declines Among U.S. Teens, HHS Survey Finds.

January 18, 2002

International Working Group Suggests Earlier Endpoints For HPV Vaccine Trials

August 29, 2014

Surveillance Following Surgery Sufficient in Stage I Seminoma

May 31, 2013